PAFAH1B3
MOLECULAR TARGETplatelet activating factor acetylhydrolase 1b catalytic subunit 3
PAFAH1B3 (platelet activating factor acetylhydrolase 1b catalytic subunit 3) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PAFAH1B3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Kaempferols | 0.69 | 1 |
| 2 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 3 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 0.69 | 1 |
| 4 | Ethidium | 0.69 | 1 |
| 5 | Nadolol | 0.69 | 1 |
| 6 | Oxytetracycline | 0.69 | 1 |
About PAFAH1B3 as a Drug Target
PAFAH1B3 (platelet activating factor acetylhydrolase 1b catalytic subunit 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented PAFAH1B3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PAFAH1B3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.